MONTGOMERYVILLE, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (NASDAQ:PHMD), a leader in the development of proprietary excimer laser systems and science based skin care products, today announced a broad extension of its therapeutic product offerings to U.S. dermatologists in anticipation of its planned acquisition of Photo Therapeutics Limited.
